Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain

被引：11

作者：

Adams, Gregory L. ^{[1
]}

Pall, Parul S. ^{[1
]}

Grauer, Steven M. ^{[1
]}

Zhou, Xiaoping ^{[1
]}

Ballard, Jeanine E. ^{[1
]}

Vavrek, Marissa ^{[1
]}

Kraus, Richard L. ^{[1
]}

Morissette, Pierre ^{[1
]}

Li, Nianyu ^{[1
]}

Colarusso, Stefania ^{[2
]}

Bianchi, Elisabetta ^{[2
]}

Palani, Anandan ^{[3
]}

Klein, Rebecca ^{[1
]}

John, Christopher T. ^{[1
]}

Wang, Deping ^{[1
]}

Tudor, Matthew ^{[1
]}

Nolting, Andrew F. ^{[1
]}

Biba, Mirlinda ^{[4
]}

Nowak, Timothy ^{[3
]}

Makarov, Alexey A. ^{[4
]}

Reibarkh, Mikhail ^{[4
]}

Buevich, Alexei, V ^{[3
]}

Zhong, Wendy ^{[4
]}

Regalado, Erik L. ^{[4
]}

Wang, Xiao ^{[4
]}

Gao, Qi ^{[4
]}

Shahripour, Aurash ^{[1
]}

Zhu, Yuping ^{[3
]}

de Simone, Daniele ^{[2
]}

Frattarelli, Tommaso ^{[2
]}

Pasquini, Nicolo' Maria ^{[2
]}

Magotti, Paola ^{[2
,5
]}

Iaccarino, Roberto ^{[2
]}

Li, Yuxing ^{[1
]}

Solly, Kelli ^{[1
]}

Lee, Keun-Joong ^{[4
]}

Wang, Weixun ^{[1
]}

Chen, Feifei ^{[1
]}

Zeng, Haoyu ^{[1
]}

Wang, Jixin ^{[1
]}

Regan, Hilary ^{[1
]}

Amin, Rupesh P. ^{[1
]}

Regan, Christopher P. ^{[1
]}

Burgey, Christopher S. ^{[1
]}

Henze, Darrell A. ^{[1
]}

Sun, Chengzao ^{[1
,6
]}

Tellers, David M. ^{[1
]}

机构：

[1] Merck & Co Inc, West Point, PA 19486 USA

[2] IRBM Spa, Peptides & Small Mol R&D Dept, I-00071 Pomezia, RM, Italy

[3] Merck & Co Inc, Kenilworth, NJ 07033 USA

[4] Merck & Co Inc, Rahway, NJ 07065 USA

[5] Gubra ApS, Horsholm Kongevej 11B, DK-2970 Horsholm, Denmark

[6] Janssen Res & Dev, Mailstop 42-2512A,1400 McKean Rd, Spring House, PA 19477 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2022年 / 65卷 / 01期

关键词：

GATED SODIUM-CHANNELS; LIPID-BILAYERS; VOLTAGE SENSOR; SPIDER PEPTIDE; HUWENTOXIN-IV; ION CHANNELS; INHIBITION; SUBTYPE; ACTIVATION; ZICONOTIDE;

D O I：

10.1021/acs.jmedchem.1c01570

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibitor cystine knot peptides, derived from venom, have evolved to block ion channel function but are often toxic when dosed at pharmacologically relevant levels in vivo. The article describes the design of analogues of ProTx-II that safely display systemic in vivo blocking of Na(v)1.7, resulting in a latency of response to thermal stimuli in rodents. The new designs achieve a better in vivo profile by improving ion channel selectivity and limiting the ability of the peptides to cause mast cell degranulation. The design rationale, structural modeling, in vitro profiles, and rat tail flick outcomes are disclosed and discussed.

引用

页码：485 / 496

页数：12

共 22 条

[1] The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Nav1.7
Wright, Zoe V. F.
McCarthy, Stephen
Dickman, Rachael
Reyes, Francis E.
Sanchez-Martinez, Silvia
Cryar, Adam
Kilford, Ian
Hall, Adrian
Takle, Andrew K.
Topf, Maya
Gonen, Tamir
Thalassinos, Konstantinos
Tabor, Alethea B.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2017, 139 (37) : 13063 - 13075
[2] Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7
Henriques, Sonia Troeira
Deplazes, Evelyne
Lawrence, Nicole
Cheneval, Olivier
Chaousis, Stephanie
Inserra, Marco
Thongyoo, Panumart
King, Glenn F.
Mark, Alan E.
Vetter, Irina
Craik, David J.
Schroeder, Christina I.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (33) : 17049 - 17065
[3] A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site
Rajamani, Ramkumar
Wu, Sophie
Rodrigo, Iyoncy
Gao, Mian
Low, Simon
Megson, Lisa
Wensel, David
Pieschl, Rick L.
Post-Munson, Debra J.
Watson, John
Langley, David R.
Ahlijanian, Michael K.
Bristow, Linda J.
Herrington, James
MOLECULAR PHARMACOLOGY, 2017, 92 (03) : 310 - 317
[4] Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain
Shcherbatko, Anatoly
Rossi, Andrea
Foletti, Davide
Zhu, Guoyun
Bogin, Oren
Casas, Meritxell Galindo
Rickert, Mathias
Hasa-Moreno, Adela
Bartsevich, Victor
Crameri, Andreas
Steiner, Alexander R.
Henningsen, Robert
Gill, Avinash
Pons, Jaume
Shelton, David L.
Rajpal, Arvind
Strop, Pavel
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (27) : 13974 - 13986
[5] Nav1.7 inhibitors for the treatment of chronic pain
McKerrall, Steven J.
Sutherlin, Daniel P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (19) : 3141 - 3149
[6] Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a
Deuis, Jennifer R.
Dekan, Zoltan
Wingerd, Joshua S.
Smith, Jennifer J.
Munasinghe, Nehan R.
Bhola, Rebecca F.
Imlach, Wendy L.
Herzig, Volker
Armstrong, David A.
Rosengren, K. Johan
Bosmans, Frank
Waxman, Stephen G.
Dib-Hajj, Sulayman D.
Escoubas, Pierre
Minett, Michael S.
Christie, Macdonald J.
King, Glenn F.
Alewood, Paul F.
Lewis, Richard J.
Wood, John N.
Vetter, Irina
SCIENTIFIC REPORTS, 2017, 7
[7] Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel
Murray, Justin K.
Ligutti, Joseph
Liu, Dong
Zou, Anruo
Poppe, Leszek
Li, Hongyan
Andrews, Kristin L.
Moyer, Bryan D.
McDonough, Stefan I.
Favreau, Philippe
Stoecklin, Reto
Miranda, Les P.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) : 2299 - 2314
[8] Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core
Wang, Jin-tao
Zheng, Yue-ming
Chen, Yue-ting
Gu, Min
Gao, Zhao-bing
Nan, Fa-jun
ACTA PHARMACOLOGICA SINICA, 2020, 41 (03) : 293 - 302
[9] Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes
Storer, R. Ian
Pike, Andy
Swain, Nigel A.
Alexandrou, Aristos J.
Bechle, Bruce M.
Blakemore, David C.
Brown, Alan D.
Castle, Neil A.
Corbett, Matthew S.
Flanagan, Neil J.
Fengas, David
Johnson, M. Scott
Jones, Lyn H.
Marron, Brian E.
Payne, C. Elizabeth
Printzenhoff, David
Rawson, David J.
Rose, Colin R.
Ryckmans, Thomas
Sun, Jianmin
Theile, Jonathan W.
Torella, Rubben
Tseng, Elaine
Warmus, Joseph S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (21) : 4805 - 4811
[10] Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain
Chowdhury, Sultan
Chafeev, Mikhail
Liu, Shifeng
Sun, Jianyu
Raina, Vandna
Chui, Ray
Young, Wendy
Kwan, Rainbow
Fu, Jianmin
Cadieux, Jay A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3676 - 3681

← 1 2 3 →